Results 101 to 110 of about 5,713,410 (258)

Upacicalcet: A Novel Intravenous Calcimimetic Agent for Patients Undergoing Hemodialysis With Secondary Hyperparathyroidism

Therapeutic Apheresis and Dialysis, Volume 30, Issue 3, Page 309-322, June 2026.
ABSTRACT Secondary hyperparathyroidism (SHPT) is a common complication in patients receiving maintenance dialysis, driven by calcium and phosphate metabolism disturbances. Calcimimetics are central to the management of SHPT by enhancing calcium‐sensing receptor sensitivity and reducing parathyroid hormone secretion.
Fumihiko Koiwa, Daisuke Honda, Seigo Akari, Tadao Akizawa   +3 more
wiley   +1 more source

Clinical presentation and outcome of surgical management of primary hyperparathyroidism: A single center-based case series in Egypt

Journal of Head & Neck Physicians and Surgeons, 2017
Introduction: Primary hyperparathyroidism is an asymptomatic disease in the Western world detected during routine laboratory investigations.The differential diagnosis and the management of primary hyperparathyroidism presenting with more severe symptoms ...
Hebatallah Gamal El Din Mohamed Mahmoud
doaj   +1 more source

Microstructural Evidence for Early Childhood Stress in a Community in Transition at Hisban, Jordan

American Journal of Biological Anthropology, Volume 190, Issue 2, June 2026.
ABSTRACT Objectives Identification of stress across infancy and childhood can reflect maternal and environmental influences on early life health. In the 19th century community of Hisban, many infants died before 2 years of age with evidence of metabolic disease, including rickets, that likely ties with maternal health.
Kristina Cockerille, Akacia Propst, Bonnie Kahlon, Daniel Temple, Megan Perry   +4 more
wiley   +1 more source

Post-surgical follow-up of primary hyperparathyroidism associated with multiple endocrine neoplasia type 1

Clinics, 2012
The bone mineral density increments in patients with sporadic primary hyperparathyroidism after parathyroidectomy have been studied by several investigators, but few have investigated this topic in primary hyperparathyroidism associated with multiple ...
Flavia L. Coutinho, Delmar M. Lourenco Jr., Rodrigo A. Toledo, Fabio L. M. Montenegro, Sergio P. A. Toledo   +4 more
doaj   +1 more source

Combined Detection of Preoperative Serum Calcitonin and Carcinoembryonic Antigen in Medullary Thyroid Carcinoma: A Retrospective Multicenter Cohort Study

Health Care Science, Volume 5, Issue 3, Page 223-230, June 2026.
Compared with the detection of either marker alone, the combined detection of calcitonin (Ctn) and carcinoembryonic antigen (CEA) improved the diagnostic accuracy for medullary thyroid cancer (MTC) but did not enhance the positive predictive value (PPV).
Yu Yang, Yufei He, Bo Lin, Yuanyuan Zheng, Xinyi Deng, Wenxin Chen, Zhenbang Ke, Yue Qiu, Yuting Hong, Jiayuan Zhang, Guojie Dong, Siqi Qiao, Ziyi Xin, Xuyang Li, Tianyi Xu, Wenke Chen, Xinwen Chen, Yingtong Hou, Fenghua Lai, Jianyan Long, Zhanqiang Zhang, Xiangdong Xu, Yihao Liu   +22 more
wiley   +1 more source

Effects of Successful Parathyroidectomy on Clinical, Laboratory, and Cardiovascular Manifestations of Primary Hyperparathyroidism

Objective: Primary hyperparathyroidism (PHPT) is a disease characterized by excessive parathyroid hormone (PTH) secretion from one or more of the 4 parathyroid glands. The disease affects many organ systems and causes a variety of symptoms.
Yakup Alsancak, Mustafa Kulaksızoğlu, Melia Karaköse, Muhammet Kocabaş, Feridun Karakurt, Kamile Büşra Çakıl   +5 more
core   +1 more source

Primary Hyperparathyroidism in Pregnancy: Successful Parathyroidectomy during First Trimester

Case Reports in Endocrinology, 2018
Primary hyperparathyroidism in pregnancy can result in significant maternal and fetal complications. When indicated, prompt parathyroidectomy in the early second trimester is considered the treatment of choice.
Niranjan Tachamo, Bidhya Timilsina, Rashmi Dhital, Theresa Lynn, Vasudev Magaji, Ilan Gabriely   +5 more
doaj   +1 more source

Breast cancer associated with primary hyperparathyroidism: A nested case control study

, 2011
Sophie Norenstedt1,7, Fredrik Granath2, Anders Ekbom2, Jonas Bergh3, Mats Lambe4, Jan Adolfsson5, Fredrik Warnberg6, Jan Zedenius1,7, Inga-Lena Nilsson1,71Department of Molecular Medicine and Surgery, 2Department of Medicine, 3Department of Oncology and ...
Norenstedt S, Granath F, Ekbom A, Bergh J, Lambe M,  Adolfsson J, Warnberg F,  Zedenius J, Nilsson I-L   +1 more
core  

A Case Report of a Special Type of Multiple Myeloma: Kappa Light Chain‐Only

Organ Medicine, Volume 3, Issue 2, Page 119-124, June 2026.
This case illustrates the clinical course of a patient diagnosed with kappa light chain‐only multiple myeloma, a rare subtype of multiple myeloma. Of note, light chain multiple myeloma is characterized by rapid disease progression and severe target organ damage.
Yanhua Dai, Yuanyue Guan, Shiwei Cui, Yuan Gao, Zhipeng Zhao, Rui Li, Li Song, Xiuying Zhao, Runqing Li   +8 more
wiley   +1 more source

Changes in clinical and laboratory findings at the time of diagnosis of primary hyperparathyroidism in a University Hospital in São Paulo from 1985 to 2002

Brazilian Journal of Medical and Biological Research, 2005
In contrast to most developed countries, most patients with primary hyperparathyroidism in Brazil are still symptomatic at diagnosis. However, we have been observing a change in this pattern, especially in the last few years.
M.N. Ohe, R.O. Santos, E.R. Barros, A. Lage, I.S. Kunii, M. Abrahão, O. Cervantes, O.M. Hauache, M. Lazaretti-Castro, J.G.H. Vieira   +9 more
doaj   +1 more source